title: Molecular genetic analysis of the FMR-1 gene in a large collection of autistic patients.
abstract: A genetic etiology in autism is now strongly supported by family and twin studies. A 3:1 ratio of affected males to females suggests the involvement of at least one X-linked locus in the disease. Several reports have indicated an association of the fragile X chromosomal anomaly at Xq27.3 (FRAXA) with autism, whereas others have not supported this finding. We have so far collected blood from 105 simplex and 18 multiplex families and have assessed 141 patients by using the Autism Diagnostic Interview-Revised (ADI-R), the Autism Diagnostic Observation Scale, and psychometric tests. All four ADI-R algorithm criteria were met by 131 patients (93%), whereas 10 patients (7%) showed a broader phenotype of autism. Southern blot analysis was performed with three different enzymes, and filters were hybridized to an FMR-1-specific probe to detect amplification of the CCG repeat at FRAXA, to the complete FMR-1 cDNA probe, and to additional probes from the neighborhood of the gene. No significant changes were found in 139 patients (99%) from 122 families, other than the normal variations in the population. In the case of one multiplex family with three children showing no dysmorphic features of the fragile X syndrome (one male meeting 3 out of 4 ADI-algorithm criteria, one normal male with slight learning disability but negative ADI-R testing, and one fully autistic female), the FRAXA full-mutation-specific CCG-repeat expansion in the genotype was not correlated with the autism phenotype. Further analysis revealed a mosaic pattern of methylation at the FMR-1 gene locus in the two sons of the family, indicating at least a partly functional gene. Therefore, we conclude that the association of autism with fragile X at Xq27.3 is non-existent and exclude this location as a candidate gene region for autism.
authors.affiliation: Deutsches Krebsforschungszentrum, Molekulare Genomanalyse, Heidelberg, Germany.
authors.forename: S M
authors.initials: SM
authors.lastname: Klauck
authors.forename: E
authors.initials: E
authors.lastname: Münstermann
authors.forename: B
authors.initials: B
authors.lastname: Bieber-Martig
authors.forename: D
authors.initials: D
authors.lastname: Rühl
authors.forename: S
authors.initials: S
authors.lastname: Lisch
authors.forename: G
authors.initials: G
authors.lastname: Schmötzer
authors.forename: A
authors.initials: A
authors.lastname: Poustka
authors.forename: F
authors.initials: F
authors.lastname: Poustka
mesh_terms: D001321:Autistic Disorder / Q000175:diagnosis* / Q000235:genetics*; D015342:DNA Probes; D003937:Diagnosis, Differential; D005260:Female; D051860:Fragile X Messenger Ribonucleoprotein 1; D005600:Fragile X Syndrome / Q000235:genetics; D005819:Genetic Markers; D006801:Humans; D008297:Male; D009419:Nerve Tissue Proteins / Q000235:genetics*; D016133:Polymerase Chain Reaction; D011581:Psychological Tests; D016601:RNA-Binding Proteins; D018911:Trinucleotide Repeats
chemical_list: D015342:DNA Probes; D051860:Fragile X Messenger Ribonucleoprotein 1; D005819:Genetic Markers; D009419:Nerve Tissue Proteins; D016601:RNA-Binding Proteins; C497683:FMR1 protein, human